\n\tDanish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday, where diabetes \u200brates are among the highest in the world.<\/p>\n
\n\tAwiqli, which \u200bNovo describes as the world’s first once-weekly basal, or background long-acting, \u200cinsulin approved for clinical use, is prescribed for the treatment of type 1 and type 2 diabetes in adults, the company said, and will likely compete with daily-dose options available in the market.<\/p>\n
\n\tMore than 101 million people in India are living with diabetes, while another 136 million have prediabetes, Novo said in a statement.<\/p>\n
\n\tInsulin initiation in India is delayed by an average of 7-9 years, partly due to fear of injections, anticipated pain, and cost concerns, it said.<\/p>\n
\u00a0<\/p>\n
\n\t“We believe \u200cAwiqli will reduce the psychological and physical barriers to insulin initiation,” Novo Nordisk India Managing Director Vikrant Shrotriya said.<\/p>\n
\n\tUnlike daily basal insulin injections, typically taken once every 24 hours, Awiqli is designed to provide background insulin support throughout the week, reducing the number of injections from 365 per year to 52, Novo said.<\/p>\n
\n\tIndia’s insulin market is projected to grow from $660.5 \u200bmillion in 2025 to $916.4 million by 2034, according to IMARC, driven by rising diabetes prevalence \u200clinked to sedentary lifestyles, poor diets, and genetic predisposition.<\/p>\n
\n\tAwiqli, known generically as insulin icodec and available in a pen device, received US \u200bapproval \u200cearlier this year and has also been approved in the European Union and \u200cseveral other countries.<\/p>\n
\n\tIn India, the drug is expected to compete with other basal insulin brands such as Sanofi’s Lantus, as well as lower-cost \u200cinsulin \u200bglargine products marketed \u200bby domestic companies including domestic drugmakers including Biocon, Eris Lifesciences and Lupin.<\/p>\n
\n\tSeparately, Novo is competing with Eli Lilly and a growing number \u200cof Indian generic \u200bdrugmakers in the country’s expanding obesity treatment market.<\/p>\n","protected":false},"excerpt":{"rendered":"
Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday, where diabetes…\n","protected":false},"author":2,"featured_media":126715,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[27733,27724,15786,18205,2016,61822,61821,272,27560,41222,2142,61775],"class_list":["post-126714","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-awiqli","tag-basal-insulin","tag-diabetes","tag-diabetes-treatment","tag-healthcare","tag-india-diabetes","tag-insulin-injection","tag-novo-nordisk","tag-pharmaceutical-industry","tag-type-1-diabetes","tag-type-2-diabetes","tag-weekly-insulin"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116893644653510023","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/126714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=126714"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/126714\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/126715"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=126714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=126714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=126714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}